Filter Results :

Your search for Healthcare returned 5201 reports

Sort by


Top Trends in Healthcare and OTC; Exploring the over-the-counter medication; vitamins, minerals and supplements; functional food and drink; and sports nutrition categories

19 May 2016  |  Published by:  Canadean
Summary The market for healthcare and OTC is primarily driven by the Health & Wellness megatrend, but manufacturers must look beyond health functionality alone to remain relevant in an ever-evolving category. Pharmaceutical, sports nutrition, and healthcare companies must draw on inspir...

$ 3,450.00

Read More

Ecuador Pharmaceuticals and Healthcare Report

18 May 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: Chinese investment in Ecuador's pharmaceutical and healthcare sector will continue to be pertinent for the country in order for it to meet the increasing demand of medicines within its public healthcare sector. Foreign generic drugmakers will, however, face significant competition fr...

$ 1,295.00

Read More

Australia Pharmaceuticals and Healthcare Report

18 May 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: Drugmakers operating in Australia will face an increasingly challenging business environment as the Sixth Pharmacy Community Agreement's measures come into effect. This includes a 5% price cut to medicines listed on the F1 formulary for more than five years, as well as changes to the...

$ 1,295.00

Read More

Indonesia Pharmaceuticals and Healthcare Report

18 May 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: The Indonesian medical landscape will see a larger presence of private healthcare providers over medium term. Underpinning this expansion is the robust prospects for the industry, with the introduction of a Coordination of Benefits scheme allowing patients to supplement their coverag...

$ 1,295.00

Read More

Estonia Pharmaceuticals and Healthcare Report

18 May 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: Estonia's healthcare system is much more mature than its Central and Eastern European peers, but given the country's limited resources, the country is less appealing to pharmaceutical companies. Drugmakers can expect to see constrained revenue growth in the country as pricing pressur...

$ 1,295.00

Read More

Kuwait Pharmaceuticals and Healthcare Report

18 May 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: With the recent oil strike representing a harbinger of significant political and economic turbulence ahead, the stability of its health and pharmaceutical sectors will depend on Kuwait's integration with neighbouring Gulf states and international partners. Headline Expenditure Proje...

$ 1,295.00

Read More

Kenya Pharmaceuticals and Healthcare Report

18 May 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: Many emerging market economies are increasingly exposed to the negative effect of sustained lower commodity prices. This is putting downward pressure on government finances and, as a consequence, healthcare budgets. We nevertheless maintain a positive long-term outlook for medicine d...

$ 1,295.00

Read More

France Pharmaceuticals and Healthcare Report

18 May 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: Despite the ongoing recovery in some high frequency indicators, subdued economic growth in France relative to regional peers will continue to weigh on the French government spending potential, posing downside risks to our pharmaceutical and healthcare sector forecasts. In line with o...

$ 1,295.00

Read More

Cameroon Pharmaceuticals and Healthcare Report

18 May 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: Although Cameroon's economic growth is expected to remain on track driven by public-private partnerships in strategic infrastructure projects, the country's pharmaceutical and healthcare sector will remain dependent on private out-of-pocket spending and global aid funds, which will w...

$ 1,295.00

Read More

Kazakhstan Pharmaceuticals and Healthcare Report

11 May 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: The mid-term outlook for Kazakhstan's pharmaceutical and healthcare markets is mixed. The healthcare system is set to improve, with the introduction of a public health insurance system and e-health technology; however, the formation of the Eurasian Economic Union medicines market is ...

$ 1,295.00

Read More

Argentina Pharmaceuticals and Healthcare Report

11 May 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: In the near term, the substandard regulatory and market access environment will continue to tarnish Argentina's appeal to drugmakers. However, in the long term, Argentina stands among the most promising pharmaceutical markets in Latin America in terms of growth. In fact, rising deman...

$ 1,295.00

Read More

Czech Republic Pharmaceuticals and Healthcare Report

11 May 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: The Czech Republic will continue to be one of the most attractive markets in the CEE region for pharmaceutical and healthcare investment. A strong economic outlook will be the driving factor behind growth and with plans to further increase access to healthcare, pharmaceutical sales a...

$ 1,295.00

Read More

Bahrain Pharmaceuticals and Healthcare Report

11 May 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: Bahrain's pharmaceutical market will experience slight growth in 2016 as a result of medicine price cuts implemented in late 2015. The country's rising prevalence of lifestyle-related diseases and the uptake of compulsory health insurance will provide strong opportunities for multina...

$ 1,295.00

Read More

Denmark Pharmaceuticals and Healthcare Report

11 May 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: Although Denmark has a relatively small pharmaceutical market compared to its Western European counterparts, its high per capita spending makes it an attractive market for innovative drugmakers. An aging population and sizable non-communicable disease burden will drive high-value med...

$ 1,295.00

Read More

Smart Home Market by Product (Lighting Control (Timer, Daylight Sensor, Occupancy Sensor), Security & Access Control, HVAC, Entertainment, Home Healthcare and Smart Kitchen), Software & Service (Behavioral, Proactive), and Geography - Global Forecast to 2022

10 May 2016  |  Published by:  MarketsandMarkets
The Smart Home market expected to grow at a CAGR of 14.07% The global market for smart homes is expected to grow at a CAGR of 14.07% between 2016 and 2022 from USD 46.97 billion in 2015 to USD 121.73 billion by 2022. The significant advancements in the IoT market, increasing need of the con...

$ 5,650.00

Read More
Total 5201 records.